Public market insider buying at Microbix Biosystems (T:MBX)

Peter Martin Blecher, a Director, acquired 263,067 Common Shares on a control or direction basis for registered holder 6k1192S Louise Ferrie-Blecher Spousal RRSP at prices ranging from $0.360 to $0.410 between November 24th and 26th, 2020. The insider also acquired 29,085 Common Shares on a control or direction basis for registered holder Peter Blecher RRSP at a price of $0.352 on November 24th, 2020. This represents a $110,185 investment into the company's shares and an account share holdings change of 46.9%.

Microbix Biosystems is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Microbix Biosystems Inc is a Canada-based life science company and manufacturer of viral and bacterial antigens and cell, culture-based biological products and technologies. The Company has developed and acquired two technologies: Kinlytic Urokinase and LumiSort. Kinlytic Urokinase is a biologic thrombolytic drug used to treat blood clots. LumiSort is a technology for ultra-rapid and efficient sorting of somatic cells that can be used to enrich cell populations of interest. The Company's catalogue of antigens covers over 30 bacterial and viral pathogens that are implicated in maternal, pediatric, childhood, respiratory, sexually-transmitted and insect-borne diseases.